PEFICITINIB: A PROMISING HOPE FOR RA INFLAMMATION ?

Peficitinib, a experimental drug targeting SYK , presents a significant breakthrough in the management of rheumatoid arthritis . Early research studies indicate that it can effectively lessen discomfort and improve mobility in patients who have the ailment, particularly those who have responded a